ea0081p355 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022
Lisco Giuseppe
, Isabella Ramunni Maria
, De Pergola Giovanni
, Jirillo Emilio
, Guastamacchia Edoardo
, Triggiani Vincenzo
, Angelo Giagulli Vito
Background: Erectile dysfunction affects nearly half of men with type 2 diabetes (T2DM), and one-third of diabetic men have hypogonadism1. As an add-on to TRT in hypogonadal men with T2DM, Liraglutide may improve erectile function2, and dulaglutide decreased the incidence of moderate and severe ED in T2DM3.Study aims: To assess the GLP-1RA effect in T2DM men complaining of ED treated with both liraglutide and dulaglutide ...